Atrial Fibrillation (AF) is the most common sustained dysrhythmia worldwide. Although new AF treatment strategies have emerged over the last decade, a major challenge facing clinicians and researchers is the paroxysmal, often short-lived, and frequently asymptomatic nature of AF. Given that paroxysmal and asymptomatic AF is a growing clinical and public health problem, better, cheaper, and more readily available AF detection technology is needed. There is, therefore, a pressing need to develop methods for readily-accessible monitoring device as well as an accurate AF detection algorithm in order to improve patient care and reduce healthcare costs associated with treating these arrhythmias and their complications. To this end, we have previously developed sensitive, real-time realizable algorithm for accurate AF detection using commercially available, clinically applicable electrocardiographic recordings. We have also made improvement to the algorithm so that it can detect AF episode that is as short as 12 beats. Further, we have recently developed a smart phone application to measure heart interval series which can be used to detect AF in real time. Given the ever-growing popularity of smart phones, our approach to AF detection using a smart phone will give patients as well as health care providers the opportunity to monitor AF under a wide variety of conditions outside of the physician's office and outside of the patient's home. Because our approach does not involve a separate ECG sensor but instead uses only standard smart phone hardware, it is cost-effective, thereby leading to better acceptance and use by patients. Our mobile health for AF detection platform has the potential to markedly change the traditional delivery of AF healthcare, allowing for more frequent, rapid, and patient-directed AF detection. Our AF prototype using 2 minutes of iPhone 4s recordings has demonstrated a sensitivity of 99% and specificity of 97% on 76 subjects with known persistent AF who underwent electrical at the University of Massachusetts Medical Center Cardiac Electrophysiology Laboratory. Although our algorithm is robust for AF detection, a major limitation is that it is not designed to discriminate premature ventricular contractions (PVC) and premature atrial contractions (PAC) from AF. Hence, the objective of this R15 project is to enhance our real-time realizable AF algorithm for accurate detection of, and discrimination between, normal sinus rhythm, AF, PVCs, and PACs;capabilities that are not yet available. We believe this research will result in rapid translation into innovative AF detection solutions, leading to more effective monitoring and diagnosis of AF. Finally, the proposed work has the potential to significantly reduce healthcare costs and enhance patient care by accurately and rapidly establishing the diagnosis of AF in at-risk groups, thereby providing clinicians with an opportunity to prevent secondary complications of these life-threatening arrhythmias.

Public Health Relevance

We propose to develop a smart phone application for detecting arrhythmia including atrial fibrillation (AF), which is the most common arrhythmia encountered in the United States. Monitoring for AF is important because, even when this arrhythmia is minimally symptomatic or paroxysmal, it is a major cause of disability and death among Americans with increasing numbers of African American and Asian patients affected by this disease. Implementation of arrhythmia monitoring including AF, premature atrial and ventricular contractions using a smart phone will lead to a more patient-friendly and timely means of arrhythmia diagnosis, and has the potential to reduce healthcare costs.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15HL121761-01A1
Application #
8689233
Study Section
Special Emphasis Panel (ZRG1-HDM-X (81))
Program Officer
Lee, Albert
Project Start
2014-08-15
Project End
2017-07-31
Budget Start
2014-08-15
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$388,706
Indirect Cost
$88,635
Name
Worcester Polytechnic Institute
Department
Biomedical Engineering
Type
Schools of Engineering
DUNS #
041508581
City
Worcester
State
MA
Country
United States
Zip Code
01609
Sardana, Mayank; Ogunsua, Adedotun A; Spring, Matthew et al. (2016) Association of Left Atrial Function Index With Late Atrial Fibrillation Recurrence after Catheter Ablation. J Cardiovasc Electrophysiol 27:1411-1419
McMANUS, David D; Chong, Jo Woon; Soni, Apurv et al. (2016) PULSE-SMART: Pulse-Based Arrhythmia Discrimination Using a Novel Smartphone Application. J Cardiovasc Electrophysiol 27:51-7
Henninger, Nils; Goddeau Jr, Richard P; Karmarkar, Ameeta et al. (2016) Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes. Stroke 47:1486-92
Kundu, Amartya; O'Day, Kevin; Shaikh, Amir Y et al. (2016) Relation of Atrial Fibrillation in Acute Myocardial Infarction to In-Hospital Complications and Early Hospital Readmission. Am J Cardiol 117:1213-8
McManus, David D; Saczynski, Jane S; Lessard, Darleen et al. (2016) Reliability of Predicting Early Hospital Readmission After Discharge for an Acute Coronary Syndrome Using Claims-Based Data. Am J Cardiol 117:501-7
Kim, Eun-Jeong; Yin, Xiaoyan; Fontes, João D et al. (2016) Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study). Am Heart J 177:138-44
Soni, Apurv; Earon, Allison; Handorf, Anna et al. (2016) High Burden of Unrecognized Atrial Fibrillation in Rural India: An Innovative Community-Based Cross-Sectional Screening Program. JMIR Public Health Surveill 2:e159
Tisminetzky, Mayra; Gurwitz, Jerry; McManus, David D et al. (2016) Multiple Chronic Conditions and Psychosocial Limitations in Patients Hospitalized with an Acute Coronary Syndrome. Am J Med 129:608-14
Ogunsua, Adedotun A; Shaikh, Amir Y; Ahmed, Mohamed et al. (2015) Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels. Methodist Debakey Cardiovasc J 11:228-34
Shaikh, Amir Y; Esa, Nada; Martin-Doyle, William et al. (2015) Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation. Crit Pathw Cardiol 14:157-65

Showing the most recent 10 out of 13 publications